Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 25 July, 2025
    A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for people with ataxia-telangiectasia (A-T),...
    • Posted on 21 July, 2025
      Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of Alzheimer’s risk? Our new...
      • Posted on 26 June, 2025
        Pain is deeply personal, yet universally expressed through speech. But what if speech isn’t just a way we describe pain,...